Czarkowski Marek, Staszków Monika, Kostyra Kacper, Shebani Zuhier, Niemczyk Stanisław, Matuszkiewicz-Rowińska Joanna
Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.
Blood Press Monit. 2009 Oct;14(5):232-8. doi: 10.1097/mbp.0b013e328331d5b5.
The accuracy of oscillometric blood pressure (BP) measuring devices determined in resting conditions may be distorted in those under hemodialysis (HD).
The evaluation of accuracy of the Omron HEM-907 was performed in accordance with the International Protocol for validation of BP measuring devices (IP). Out of a group of 49 patients with end-stage renal disease (ESRD) (56.7 +/- 15.6 years), four groups of 33 patients each were selected to ascertain their BP before and after HD.
The Omron HEM-907 fulfilled the IP accuracy requirements for systolic BP measurements before and after HD. In the case of diastolic BP before HD, the Omron HEM-907 did not fulfill both requirements for phase 2.2 IP. In only 21 out of 33 patients, the difference between the mean of two observers and the Omron HEM-907 device (Diff) was not more than 5 mmHg, while the requirement was 22 patients. In seven patients, all three Diff were over 5 mmHg, while the accepted limit is three. After HD, the Omron HEM-907 did not fulfill one out of two criteria of phase 2.2 IP - in five people, all three Diff were over 5 mmHg.
The Omron HEM-907 oscillometric method of BP measurement should not be used to measure BP before and after HD in ESRD patients. In ESRD patients, an alternative method of BP measurement, in the event of a lack of a mercury sphygmomanometer, could be a classical auscultatory method together with the Omron HEM-907, which allows for this type of BP measurement.
在静息状态下测定的示波法血压测量设备的准确性,在接受血液透析(HD)的患者中可能会受到影响。
根据血压测量设备验证国际协议(IP)对欧姆龙HEM-907的准确性进行评估。在一组49例终末期肾病(ESRD)患者(56.7±15.6岁)中,每组选取33例患者,共四组,以确定其血液透析前后的血压。
欧姆龙HEM-907满足血液透析前后收缩压测量的IP准确性要求。在血液透析前舒张压测量方面,欧姆龙HEM-907未满足IP第2.2阶段两项要求。在33例患者中,只有21例两名观察者的平均值与欧姆龙HEM-907设备之间的差异(Diff)不超过5 mmHg,而要求为22例患者。7例患者中,所有三个Diff均超过5 mmHg,而可接受的限度是三个。血液透析后,欧姆龙HEM-907未满足第2.2阶段IP两项标准中的一项——五人中所有三个Diff均超过5 mmHg。
欧姆龙HEM-907示波法血压测量不应在ESRD患者血液透析前后用于测量血压。在ESRD患者中,如果没有汞柱式血压计,一种替代的血压测量方法可以是经典听诊法结合欧姆龙HEM-907,它允许进行这种类型的血压测量。